![]() |
市场调查报告书
商品编码
1930107
全球血管封闭装置市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考量因素以及未来预测(2026-2034)Vessel Sealing Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
由于外科手术数量的增加以及对微创手术技术需求的成长,全球血管封闭装置市场正经历稳定成长。根据 Fortune Business Insights 预测,该市场规模预计在 2025 年达到 21.1 亿美元,并在 2026 年达到 22.4 亿美元。到 2034 年,市场规模预计将达到 37.7 亿美元,在预测期(2026-2034 年)内以 6.69% 的复合年增长率成长。北美地区凭藉其先进的医疗基础设施和较高的手术率,在 2025 年以 44.82% 的市场占有率领先。
市场概览
血管封闭器是一种先进的外科器械,用于在开放式手术和腹腔镜手术中封闭动脉和静脉。这些器械包括电热双极血管封闭器、超音波剪切器和混合能量系统。它们能够有效率地闭合、切割和凝固血管,从而减少出血并改善手术效果。微创手术日益普及以及外科能量器械技术的进步是推动市场成长的关键因素。
市场驱动因素
全球外科手术数量的不断增长是血管封闭器市场的主要驱动因素。根据美国国家生物技术资讯中心 (NCBI) 发布的数据,全球每年约进行 3.1 亿例大型外科手术,光是美国每年就进行超过 4,500 万例。此外,老年人口的增长(老年人易患慢性病和心血管疾病)也导致了住院和手术量的增加。
人们对先进外科技术的认识不断提高、医疗保健支出不断增长,以及已开发国家和新兴国家训练有素的外科医生数量不断增加,都进一步加速了血管封闭装置的应用。
市场趋势
影响市场的一个关键趋势是向微创手术的转变。这些手术具有许多优势,例如减轻术后疼痛、缩短住院时间、加快復健速度、降低併发症风险。美国国家生物技术资讯中心 (NCBI) 2021 年的一项研究表明,与接受开放性手术的患者相比,接受微创手术的患者併发症更少。
全球每年约进行 1500 万例腹腔镜手术,其中约 80% 的手术使用了能量型器械,凸显了对血管封闭技术日益增长的需求。
新冠疫情的影响
2020年,新冠疫情对市场成长造成了负面影响,主要原因是择期手术的延迟以及医疗资源被重新分配用于新冠肺炎的治疗。根据Healthium MedTech Ltd.的数据显示,疫情期间全球手术量下降了约15%。供应链中断和原材料短缺进一步影响了主要製造商的设备生产和收入。
然而,随着2021年限制措施的逐步解除,手术得以恢復,推动了市场復苏,并带动了血管封闭器械需求的反弹。
依市场区隔分析
依产品类型划分,电热血管封闭器占市场主导地位,预计到2026年将保持66.68%的市场占有率,这主要得益于频繁的新产品发布以及在开放式和腹腔镜手术中的广泛应用。
依组件划分,受手术数量不断增加的推动,预计到2026年,器械类产品将占市场主导地位,市场占有率达78.77%。
依手术类型划分,微创手术和腹腔镜手术占最大占有率,而普通外科手术预计将以最高的复合年增长率增长。
依应用领域划分,受心血管疾病盛行率上升的推动,预计到2026年,心胸外科手术将占市场主导地位,市场占有率达28.80%。
依最终用户划分,受住院患者和手术数量增加的推动,预计到2026年,医院和门诊手术中心(ASC)将占市场87.80%的占有率。
依地区分析
预计到2025年,北美市场规模将达到9.5亿美元,主要得益于高额的医疗保健支出、有利的报销政策以及技术创新。
欧洲凭藉着不断增加的监管审批和产品上市,维持显着的市场占有率。
亚太地区正经历快速成长,这主要得益于人口老化以及人们对先进外科技术的日益了解。
拉丁美洲以及中东和非洲地区预计将保持稳定成长,这得益于医疗基础设施的改善和手术量的增加。
The global vessel sealing devices market is experiencing steady growth due to the increasing volume of surgical procedures and the growing preference for minimally invasive surgical techniques. According to Fortune Business Insights, the market was valued at USD 2.11 billion in 2025 and is projected to grow to USD 2.24 billion in 2026. By 2034, the market is expected to reach USD 3.77 billion, expanding at a CAGR of 6.69% during the forecast period (2026-2034). North America dominated the market with a 44.82% share in 2025, supported by advanced healthcare infrastructure and high surgical procedure rates.
Market Overview
Vessel sealing devices are advanced surgical instruments used to seal arteries and veins during open and laparoscopic surgeries. These devices include electro-thermal bipolar vessel sealers, ultrasonic shear devices, and hybrid energy systems. They enable efficient sealing, cutting, and coagulation of blood vessels, thereby reducing blood loss and improving surgical outcomes. The rising preference for minimally invasive procedures and technological advancements in surgical energy devices are key contributors to market growth.
Market Drivers
The increasing number of surgical procedures worldwide is a primary driver of the vessel sealing devices market. According to data published by the National Center for Biotechnology Information, approximately 310 million major surgeries are performed globally each year, with over 45 million surgeries conducted annually in the United States. Additionally, the growing geriatric population, which is more susceptible to chronic and cardiovascular diseases, is contributing to higher inpatient admissions and surgical volumes.
Rising awareness of advanced surgical techniques, increasing healthcare expenditure, and the growing number of trained surgeons in both developed and emerging economies are further accelerating the adoption of vessel sealing devices.
Market Trends
A significant trend shaping the market is the preferential shift toward minimally invasive surgical procedures. These procedures offer benefits such as reduced postoperative pain, shorter hospital stays, faster recovery, and lower complication risks. According to a 2021 NCBI study, patients undergoing minimally invasive surgeries experienced fewer complications compared to those undergoing open surgeries.
Approximately 15 million laparoscopic procedures are performed globally each year, and energy-based devices are used in nearly 80% of laparoscopic surgeries, highlighting the growing demand for vessel sealing technologies.
Impact of COVID-19
The COVID-19 pandemic had a negative impact on market growth in 2020, primarily due to the postponement of elective surgeries and the reallocation of healthcare resources toward COVID-19 treatment. According to Healthium MedTech Ltd., global surgical procedures declined by nearly 15% during the pandemic. Supply-chain disruptions and raw-material shortages further affected device production and revenue generation for key manufacturers.
However, the gradual lifting of restrictions in 2021 led to the resumption of surgeries, supporting market recovery and renewed demand for vessel sealing devices.
Market Segmentation Insights
By product, electro-thermal vessel sealer devices dominated the market and are projected to hold a 66.68% share in 2026, driven by frequent product launches and broad adoption in both open and laparoscopic surgeries.
By components, the instruments segment is expected to dominate with a 78.77% share in 2026, owing to rising surgical volumes.
By surgery type, laparoscopic surgery held the largest share due to its minimally invasive nature, while general surgery is expected to grow at the fastest CAGR.
By application, the cardiothoracic segment is projected to dominate with a 28.80% share in 2026, driven by the rising prevalence of cardiovascular diseases.
By end user, hospitals and ambulatory surgical centers (ASCs) are expected to account for 87.80% of the market in 2026, supported by high inpatient admissions and surgical procedure rates.
Regional Analysis
North America generated USD 0.95 billion in 2025, driven by high healthcare spending, favorable reimbursement policies, and technological innovation.
Europe held a considerable market share due to increasing regulatory approvals and product launches.
Asia Pacific is witnessing rapid growth due to a rising aging population and increasing awareness of advanced surgical technologies.
Latin America and the Middle East & Africa are expected to grow steadily, supported by improving healthcare infrastructure and increasing surgical volumes.
Competitive Landscape
The market is consolidated, with leading players such as Medtronic, Johnson & Johnson Services, Olympus Corporation, and B. Braun SE holding a strong presence. These companies focus on R&D investments, product innovation, regulatory approvals, and strategic acquisitions to strengthen their market positions.
Conclusion
The global vessel sealing devices market is set to grow from USD 2.11 billion in 2025 to USD 3.77 billion by 2034, driven by rising surgical volumes, increasing adoption of minimally invasive procedures, and continuous technological advancements. Although high device costs and limited awareness in emerging regions remain challenges, strong R&D pipelines, expanding healthcare infrastructure, and growing surgeon preference for advanced energy devices are expected to support sustained market growth during the forecast period.
Segmentation By Product
By Components
By Surgery Type
By Application
By End-user
By Region